Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has demonstrated a strong financial performance, prompting an increase in normalized Funds From Operations (NFFO) estimates for 2025 to $4.80 per share, which aligns with management's guidance range. The company’s success in exceeding earnings expectations in the second quarter of 2025 and providing an encouraging outlook has contributed to a positive sentiment around its performance. Additionally, the 2026 FFO estimate has been raised to $5.03 per share, slightly exceeding the consensus, further solidifying the optimistic outlook for the company's financial trajectory.

Bears say

National Health Investors Inc is facing a negative outlook primarily due to anticipated lower earnings growth over the coming years, reflecting operational challenges related to operator transitions and potential rent resets. The company's financial performance may further suffer if deferred rent collections are weaker than expected, or if specific operators encounter difficulties, particularly in light of uncertainties surrounding health crises. These factors collectively underscore significant risks to the company's revenue stability and overall financial health.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.